4.7 Article

Association study of the GAB2 gene with the risk of developing Alzheimer's disease

Journal

NEUROBIOLOGY OF DISEASE
Volume 30, Issue 1, Pages 103-106

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.nbd.2007.12.006

Keywords

Alzheimer; GAB2; APOE; polymorphism

Categories

Ask authors/readers for more resources

The first genome-wide association in Alzheimer's disease (AD) suggested that the GAB2 gene rs2373115 polymorphism may be a strong risk factor in APOE epsilon 4-carriers. We failed to detect an association of rs2373115 with the risk of developing AD in three populations (totalling 1406 controls and 1749 AD cases) whatever the APOE status, even if we observed a slight tendency for an increase of the GG genotype (OR (GG versus GT + TT) = 1.3, 95% CI 1.0-1.6, p=0.09) and the G allele frequency (OR=13, 95%CI 1.0-1.6, p=0.05) in e4-carriers. In addition, the rs2373115 did not modulate the extent of tau phosphorylation in the brain of 89 AD cases. The GAB2 gene is at best a minor genetic determinant of AD. (C) 2008 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available